Vertex was only bidder for Crinetics in year’s second-highest M&A premiumnews2026-07-22T10:00:34+00:00July 22nd, 2026|Endpoints News|
Trump pledges new tariffs on generic drugs not made in the USnews2026-07-22T00:38:47+00:00July 22nd, 2026|Endpoints News|
Novo sues Lilly over ‘deceptive’ ads comparing GLP-1 drug dosesnews2026-07-21T18:57:43+00:00July 21st, 2026|Endpoints News|
Indian generic drugmaker gets FDA warning over clinical study consentnews2026-07-21T17:22:24+00:00July 21st, 2026|Endpoints News|
FDA plans to name permanent center heads alongside FDA chiefnews2026-07-21T16:56:27+00:00July 21st, 2026|Endpoints News|
Novartis CEO says latest China deals are just following the sciencenews2026-07-21T15:41:54+00:00July 21st, 2026|Endpoints News|
Gilead and Merck provide HIV data; Dimension Capital announces $800M fundnews2026-07-21T15:30:57+00:00July 21st, 2026|Endpoints News|
Agios’ second shot at sickle cell disease falls shortnews2026-07-21T15:14:44+00:00July 21st, 2026|Endpoints News|
Broad Institute launches Center for Therapeutic Genetics for rare diseasesnews2026-07-21T12:00:45+00:00July 21st, 2026|Endpoints News|